This program is aimed at educating multidisciplinary professionals for the new drug industry, specializing in natural substances, composite materials and biopolymer-based biomaterials. It offers an integrated curriculum that combines knowledge and skills. It prepares students for graduate studies in new drug R&D, while giving them field experience on biomedical materials production, quality control, facilities control, licensing, marketing, and preclinical & toxicity experiment control.

Level 2: New Medical Materials / Medical Botany / Introduction to Natural Substances / Introduction to Pharmacology

Level 3: Microbiome and Disease / Disease Genomics / Biosignal Transmission System / Toxicity Studies and Pharmcokinetics

Level 4: GCP(GoodClinical Practice) & CRA(Clinical Research Associate) / Capstone Design / GMP Pharmaceutical Manufacturing Process
 

Level 2: In Vivo Metabolism and Metabolic Disease / Therapeutic Biopolymers / Introduction to Medical Chemistry / Enteric Microbiology

Level 3: New Medical Materials Synthesis / New Medical Material Drug Delivery System / Bioactivity Assessment of New Materials / Separation of Natural Substances and Structure Crystallography

Level 4: Theory of medical development and planning / Pharmaceutical Licensing / Practical Field Training

Sales approval (licensing and patenting), production (manufacturing, facilities & GMP control), sales (technology commercialization, side effect monitoring, sales), pharmaceuticals consultant or marketing specialist

Research and development during/after graduate studies in medicine or life science (R&D planning, candidate substance research, nonclinical & clinical tests)

Pharmaceutical companies, bio firms, cosmetics firms, food companies, national/public research centers, pharmaceutical consulting firms, national/public institutes related to pharmaceutical patents and licenses, clinical & nonclinical service companies, pharmaceutical distribution and marketing companies, venture startups, etc.